CVS Health to split into two separate companies, separating insurance and pharmacy operations
CVS Health announced that it will divide the business into two independent companies. One entity will house its insurance arm Aetna together with pharmacy‑benefit manager Caremark, while the other will retain the retail pharmacy and related services.
The decision reverses a previous merger that created a large health‑industry conglomerate, reflecting a broader trend of companies untangling insurance and pharmacy functions to focus on core strengths.
Analysts note that the split could reshape investor expectations for CVS, while the broader news cycle also includes FDA inspections in India and China and a failed experimental drug trial by Servier, but the primary development is the CVS restructuring.
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: Pharmalittle: We’re reading about CVS plans to split up, FDA inspections in India and China and more”
read at STAT ↗
comments(0)
5-min edit window · permanent after that